Neuland Laboratories Limited Share Price NSE India S.E.
Stocks
NEULANDLAB
INE794A01010
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19,043.00 INR | -0.83% |
|
+2.68% | +25.49% |
| Market Cap | 24TCr 256.27Cr 222.77Cr 207.35Cr 190.38Cr 359.51Cr 365.08Cr 2.44TCr 959.26Cr 12TCr 962.44Cr 941.3Cr 41TCr | P/E 2027 * |
58.3x | P/E 2028 * | 42.3x |
|---|---|---|---|---|---|
| Enterprise Value | 25TCr 259.35Cr 225.45Cr 209.84Cr 192.66Cr 363.83Cr 369.46Cr 2.47TCr 970.78Cr 12TCr 974Cr 952.6Cr 41TCr | EV / Sales 2027 * |
10.7x | EV / Sales 2028 * | 8.87x |
| Free-Float |
62.26% | Yield 2027 * |
0.07% | Yield 2028 * | 0.1% |
Last Transcript: Neuland Laboratories Limited
| 1 day | -0.83% | ||
| 1 week | +2.68% | ||
| 1 month | +1.37% | ||
| 3 months | +26.93% | ||
| 6 months | +40.66% | ||
| Current year | +25.49% |
| 1 week | 18,471 |  | 19,815 |
| 1 month | 18,055 | | 20,089 |
| Current year | 11,500 | | 20,089 |
| 1 year | 11,500 | | 20,089 |
| 3 years | 3,350 | | 20,089 |
| 5 years | 967 | | 20,089 |
| 10 years | 245.75 | | 20,089 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 47 | 01/04/2026 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 23/11/2022 |
Ajitabh Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 01/01/2002 | |
| Chairman | 82 | 07/01/1984 | |
| Director/Board Member | 47 | 01/03/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.83% | +2.68% | - | - | 256.27Cr | |
| -0.53% | -3.95% | +50.70% | +153.56% | 1,02400Cr | |
| +0.21% | -2.68% | +53.20% | +51.79% | 62TCr | |
| -2.51% | -3.25% | +28.54% | +68.94% | 44TCr | |
| +0.06% | -0.42% | +37.53% | +30.67% | 35TCr | |
| -0.14% | -0.24% | +34.41% | +39.01% | 30TCr | |
| -0.69% | -0.30% | +13.76% | +12.83% | 26TCr | |
| -7.37% | -4.40% | -0.74% | -44.28% | 21TCr | |
| -0.64% | +2.43% | +29.74% | +65.93% | 21TCr | |
| -0.82% | +0.70% | +15.05% | +72.05% | 16TCr | |
| Average | -1.33% | -1.20% | +29.13% | +50.05% | 39.71TCr | |
| Weighted average by Cap. | -0.99% | -1.93% | +37.18% | +73.22% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 230.68Cr 91Cr 1.15TCr 91Cr 89Cr 3.85TCr | 2.78TCr 29Cr 25Cr 24Cr 22Cr 41Cr 41Cr 277.74Cr 109Cr 1.38TCr 109.37Cr 106.96Cr 4.64TCr |
| Net income | 420.93Cr 4.41Cr 3.83Cr 3.57Cr 3.28Cr 6.19Cr 6.28Cr 42Cr 17Cr 209.56Cr 17Cr 16Cr 702.69Cr | 580.63Cr 6.08Cr 5.29Cr 4.92Cr 4.52Cr 8.53Cr 8.67Cr 58Cr 23Cr 289.06Cr 23Cr 22Cr 969.28Cr |
| Net Debt | 293.75Cr 3.08Cr 2.67Cr 2.49Cr 2.29Cr 4.32Cr 4.38Cr 29Cr 12Cr 146.24Cr 12Cr 11Cr 490.37Cr | 192.03Cr 2.01Cr 1.75Cr 1.63Cr 1.49Cr 2.82Cr 2.87Cr 19Cr 7.53Cr 96Cr 7.55Cr 7.39Cr 320.56Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | ₹19,043.00 | -0.83% | 53,991 |
| 30/26/30 | ₹19,202.00 | -2.51% | 55,859 |
| 29/26/29 | ₹19,697.00 | +4.38% | 41,310 |
| 28/26/28 | ₹18,871.00 | -0.65% | 15,593 |
| 27/26/27 | ₹18,994.00 | +2.42% | 27,760 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 524558 Stock
- NEULANDLAB Stock
Select your edition
All financial news and data tailored to specific country editions
